| pubmed-article:17262850 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17262850 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:17262850 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17262850 | lifeskim:mentions | umls-concept:C0289884 | lld:lifeskim |
| pubmed-article:17262850 | lifeskim:mentions | umls-concept:C0751964 | lld:lifeskim |
| pubmed-article:17262850 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17262850 | pubmed:dateCreated | 2007-2-5 | lld:pubmed |
| pubmed-article:17262850 | pubmed:abstractText | To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis. | lld:pubmed |
| pubmed-article:17262850 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17262850 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17262850 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17262850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17262850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17262850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17262850 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17262850 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17262850 | pubmed:issn | 0364-5134 | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:MillerAaronA | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:O'ConnorPaulP | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:NarayanaPonna... | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:WolinskyJerry... | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:CoylePatricia... | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:JohnsonKennet... | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:LadkaniDavidD | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:PROMiSe... | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:FordCoreyC | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:PardoLillianL | lld:pubmed |
| pubmed-article:17262850 | pubmed:author | pubmed-author:KadoshShaulS | lld:pubmed |
| pubmed-article:17262850 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17262850 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:17262850 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17262850 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17262850 | pubmed:pagination | 14-24 | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:meshHeading | pubmed-meshheading:17262850... | lld:pubmed |
| pubmed-article:17262850 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17262850 | pubmed:articleTitle | Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. | lld:pubmed |
| pubmed-article:17262850 | pubmed:affiliation | Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA. jerry.s.wolinsky@uth.tmc.edu | lld:pubmed |
| pubmed-article:17262850 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17262850 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:17262850 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17262850 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17262850 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17262850 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17262850 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17262850 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17262850 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17262850 | lld:pubmed |
